These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2730451)

  • 1. Mitozantrone--out of the blue.
    Smith G
    Aust Nurses J; 1989 Mar; 18(8):28. PubMed ID: 2730451
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic milestones. Novantrone (mitozantrone).
    Cotter FE
    Br J Clin Pract; 1988 May; 42(5):207-9. PubMed ID: 3063315
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitozantrone-induced onycholysis. A series of five cases.
    Creamer JD; Mortimer PS; Powles TJ
    Clin Exp Dermatol; 1995 Nov; 20(6):459-61. PubMed ID: 8857336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitozantrone.
    Drug Ther Bull; 1986 Sep; 24(18):71-2. PubMed ID: 3757795
    [No Abstract]   [Full Text] [Related]  

  • 5. An overview of mitozantrone.
    Birchall LA; Bailey NP; Blackledge GR
    Br J Clin Pract; 1991; 45(3):208-11. PubMed ID: 1805919
    [No Abstract]   [Full Text] [Related]  

  • 6. Anthracyclines.
    Hamilton D; Batist G
    Cancer Chemother Biol Response Modif; 2005; 22():19-33. PubMed ID: 16110606
    [No Abstract]   [Full Text] [Related]  

  • 7. [Green urine].
    Sauter C
    Schweiz Med Wochenschr; 1998 Dec; 128(50):2003. PubMed ID: 9888172
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment evaluation in active control studies.
    Fleming TR
    Cancer Treat Rep; 1987 Nov; 71(11):1061-5. PubMed ID: 3119201
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of low-dose mitozantrone to treat aggressive multiple sclerosis: a single-centre open-label study using patient self-assessment and clinical measures of multiple sclerosis status.
    Ostberg A; Pittas F; Taylor B
    Intern Med J; 2005 Jul; 35(7):382-7. PubMed ID: 15958106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone in elderly women with advanced breast cancer: a phase II study.
    Repetto L; Simoni C; Venturino A; Biancardi V; Gasco M; Campora E; Rosso R
    Anticancer Res; 1995; 15(5B):2297-300. PubMed ID: 8572641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving clinical strategies: innovative approaches to the use of mitoxantrone--introduction.
    Powles TJ
    Eur J Cancer Care (Engl); 1997 Dec; 6(4 Suppl):1-3. PubMed ID: 9460335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukaemia due to mitoxantrone.
    Prescrire Int; 2007 Aug; 16(90):153-6. PubMed ID: 17724842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitozantrone-induced onycholysis.
    Speechly-Dick ME; Owen ER
    Lancet; 1988 Jan; 1(8577):113. PubMed ID: 2891948
    [No Abstract]   [Full Text] [Related]  

  • 14. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
    Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
    J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mitoxantrone--a new cytostatic agent].
    Klein HO
    Fortschr Med; 1985 Feb; 103(8):229-30. PubMed ID: 3979939
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitoxantrone: a promising new chemotherapeutic agent.
    Dalton WS; Alberts DS
    Ariz Med; 1984 Feb; 41(2):96-8. PubMed ID: 6703919
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phase II study of mitoxantrone in advanced breast cancer].
    Ogawa M; Kubo K; Tominaga T; Nomura Y; Ota K; Yoshida M; Taguchi T; Hoshino A
    Gan To Kagaku Ryoho; 1986 May; 13(5):1980-4. PubMed ID: 3707156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of mitoxantrone in the treatment of hormone-independent metastatic cancer of the prostate].
    Culine S
    Prog Urol; 2002 Feb; 12(1 Suppl 2):31-5. PubMed ID: 11980025
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitoxantrone.
    Med Lett Drugs Ther; 1988 Jul; 30(769):67-8. PubMed ID: 3380059
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitozantrone.
    Lancet; 1984 Aug; 2(8397):265-6. PubMed ID: 6146814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.